{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:50:55Z","timestamp":1791874255599,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/ni.3444","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T11:40:19Z","timestamp":1461584419000},"page":"636-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":465,"title":["IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs"],"prefix":"10.1038","volume":"17","author":[{"given":"Suzanne M","family":"Bal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem H","family":"Bernink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medya M","family":"Shikhagaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornel","family":"Golebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis M","family":"van Drunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Lutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene E","family":"Jonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pleun","family":"Hombrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bruchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Villaudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Marius","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas S","family":"Erjef\u00e4lt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Romero","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,25]]},"reference":[{"key":"BFni3444_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes, P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8, 183\u2013192 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3444_CR2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cea.12472","volume":"45","author":"KE Hulse","year":"2015","unstructured":"Hulse, K.E., Stevens, W.W., Tan, B.K. & Schleimer, R.P. Pathogenesis of nasal polyposis. Clin. Exp. Allergy 45, 328\u2013346 (2015).","journal-title":"Clin. Exp. Allergy"},{"key":"BFni3444_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","volume":"132","author":"DR Nagarkar","year":"2013","unstructured":"Nagarkar, D.R. et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J. Allergy. Clin. Immunol. 132, 593\u2013600 (2013).","journal-title":"J. Allergy. Clin. Immunol."},{"key":"BFni3444_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2500\/ajra.2010.24.3446","volume":"24","author":"DD Reh","year":"2010","unstructured":"Reh, D.D., Wang, Y., Ramanathan, M. Jr. & Lane, A.P. Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33. Am. J. Rhinol. Allergy 24, 105\u2013109 (2010).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"BFni3444_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1165\/rcmb.2009-0220TR","volume":"41","author":"PJ Barnes","year":"2009","unstructured":"Barnes, P.J. The cytokine network in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 41, 631\u2013638 (2009).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFni3444_CR6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2015.02.011","volume":"42","author":"J Kearley","year":"2015","unstructured":"Kearley, J. et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity 42, 566\u2013579 (2015).","journal-title":"Immunity"},{"key":"BFni3444_CR7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nri3739","volume":"14","author":"MJ Holtzman","year":"2014","unstructured":"Holtzman, M.J., Byers, D.E., Alexander-Brett, J. & Wang, X. The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat. Rev. Immunol. 14, 686\u2013698 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3444_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","volume":"41","author":"AN McKenzie","year":"2014","unstructured":"McKenzie, A.N., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366\u2013374 (2014).","journal-title":"Immunity"},{"key":"BFni3444_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293\u2013301 (2015).","journal-title":"Nature"},{"key":"BFni3444_CR10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","volume":"464","author":"S Buonocore","year":"2010","unstructured":"Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371\u20131375 (2010).","journal-title":"Nature"},{"key":"BFni3444_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature11813","volume":"494","author":"CS Klose","year":"2013","unstructured":"Klose, C.S. et al. A T-bet gradient controls the fate and function of CCR6-ROR\u03b3t+ innate lymphoid cells. Nature 494, 261\u2013265 (2013).","journal-title":"Nature"},{"key":"BFni3444_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink, J.H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221\u2013229 (2013).","journal-title":"Nat. Immunol."},{"key":"BFni3444_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","volume":"134","author":"KR Bartemes","year":"2014","unstructured":"Bartemes, K.R., Kephart, G.M., Fox, S.J. & Kita, H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 134, 671\u2013678 (2014).","journal-title":"J Allergy Clin Immunol"},{"key":"BFni3444_CR14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaci.2015.06.038","volume":"137","author":"P Nagakumar","year":"2015","unstructured":"Nagakumar, P. et al. Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J. Allergy Clin. Immunol. 137, 624\u2013626.e6 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFni3444_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mj\u00f6sberg","year":"2011","unstructured":"Mj\u00f6sberg, J.M. et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055\u20131062 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni3444_CR16","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","volume":"210","author":"M Salimi","year":"2013","unstructured":"Salimi, M. et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210, 2939\u20132950 (2013).","journal-title":"J. Exp. Med."},{"key":"BFni3444_CR17","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/jid.2014.146","volume":"134","author":"MB Teunissen","year":"2014","unstructured":"Teunissen, M.B. et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR+ ILC3 in lesional skin and blood of psoriasis patients. J. Invest. Dermatol. 134, 2351\u20132360 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"BFni3444_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim, H.Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54\u201361 (2014).","journal-title":"Nat. Med."},{"key":"BFni3444_CR19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.aac9593","volume":"350","author":"G Gasteiger","year":"2015","unstructured":"Gasteiger, G., Fan, X., Dikiy, S., Lee, S.Y. & Rudensky, A.Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981\u2013985 (2015).","journal-title":"Science"},{"key":"BFni3444_CR20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink, J.H. et al. Interleukin-12 and -23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146\u2013160 (2015).","journal-title":"Immunity"},{"key":"BFni3444_CR21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.immuni.2010.10.017","volume":"33","author":"C Vonarbourg","year":"2010","unstructured":"Vonarbourg, C. et al. Regulated expression of nuclear receptor ROR\u03b3t confers distinct functional fates to NK cell receptor-expressing ROR\u03b3t+ innate lymphocytes. Immunity 33, 736\u2013751 (2010).","journal-title":"Immunity"},{"key":"BFni3444_CR22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood-2013-11-427781","volume":"124","author":"MD Hazenberg","year":"2014","unstructured":"Hazenberg, M.D. & Spits, H. Human innate lymphoid cells. Blood 124, 700\u2013709 (2014).","journal-title":"Blood"},{"key":"BFni3444_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.ai.2014.09.004","volume":"125","author":"B Roediger","year":"2015","unstructured":"Roediger, B. & Weninger, W. Group 2 innate lymphoid cells in the regulation of immune responses. Adv. Immunol. 125, 111\u2013154 (2015).","journal-title":"Adv. Immunol."},{"key":"BFni3444_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","volume":"519","author":"JR Brestoff","year":"2015","unstructured":"Brestoff, J.R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242\u2013246 (2015).","journal-title":"Nature"},{"key":"BFni3444_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","volume":"37","author":"J Mj\u00f6sberg","year":"2012","unstructured":"Mj\u00f6sberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649\u2013659 (2012).","journal-title":"Immunity"},{"key":"BFni3444_CR26","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1182\/blood-2004-02-0656","volume":"104","author":"R Gimeno","year":"2004","unstructured":"Gimeno, R. et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2\u2212\/\u2212 \u03b3c\u2212\/\u2212 mice: functional inactivation of p53 in developing T cells. Blood 104, 3886\u20133893 (2004).","journal-title":"Blood"},{"key":"BFni3444_CR27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.immuni.2010.06.007","volume":"32","author":"T Hughes","year":"2010","unstructured":"Hughes, T. et al. Interleukin-1\u03b2 selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 32, 803\u2013814 (2010).","journal-title":"Immunity"},{"key":"BFni3444_CR28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722\u2013725 (2009).","journal-title":"Nature"},{"key":"BFni3444_CR29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1165\/rcmb.2013-0369OC","volume":"51","author":"TL Hackett","year":"2014","unstructured":"Hackett, T.L., Shaheen, F., Zhou, S., Wright, J.L. & Churg, A. Fibroblast signal transducer and activator of transcription 4 drives cigarette smoke-induced airway fibrosis. Am. J. Respir. Cell Mol. Biol. 51, 830\u2013839 (2014).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFni3444_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0602-567","volume":"8","author":"MF Neurath","year":"2002","unstructured":"Neurath, M.F., Finotto, S. & Glimcher, L.H. The role of Th1\/Th2 polarization in mucosal immunity. Nat. Med. 8, 567\u2013573 (2002).","journal-title":"Nat. Med."},{"key":"BFni3444_CR31","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/all.12440","volume":"69","author":"D Miljkovic","year":"2014","unstructured":"Miljkovic, D. et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 69, 1154\u20131161 (2014).","journal-title":"Allergy"},{"key":"BFni3444_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1074-7613(04)00026-3","volume":"20","author":"D Voehringer","year":"2004","unstructured":"Voehringer, D., Shinkai, K. & Locksley, R.M. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20, 267\u2013277 (2004).","journal-title":"Immunity"},{"key":"BFni3444_CR33","doi-asserted-by":"crossref","first-page":"e01659","DOI":"10.7554\/eLife.01659","volume":"3","author":"DK Sojka","year":"2014","unstructured":"Sojka, D.K. et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. eLife 3, e01659 (2014).","journal-title":"eLife"},{"key":"BFni3444_CR34","doi-asserted-by":"crossref","unstructured":"Silver, J.S. et al. Inflammatory triggers associated with COPD exacerbations orchestrate ILC2 plasticity in the lung. Nat. Immunol. doi:10.1038\/ni.3443 (2016).10.1038\/ni.3443","DOI":"10.1038\/ni.3443"},{"key":"BFni3444_CR35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaci.2015.05.052","volume":"136","author":"PJ Barnes","year":"2015","unstructured":"Barnes, P.J. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J. Allergy Clin. Immunol. 136, 531\u2013545 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFni3444_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","volume":"43","author":"AB Molofsky","year":"2015","unstructured":"Molofsky, A.B. et al. Interleukin-33 and interferon-\u03b3 counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 43, 161\u2013174 (2015).","journal-title":"Immunity"},{"key":"BFni3444_CR37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","volume":"502","author":"JC Nussbaum","year":"2013","unstructured":"Nussbaum, J.C. et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245\u2013248 (2013).","journal-title":"Nature"},{"key":"BFni3444_CR38","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1476-5381.2012.01907.x","volume":"166","author":"T Southworth","year":"2012","unstructured":"Southworth, T. et al. IFN-\u03b3 synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation. Br. J. Pharmacol. 166, 2070\u20132083 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFni3444_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3858\/emm.2011.43.4.018","volume":"43","author":"BJ Lee","year":"2011","unstructured":"Lee, B.J. et al. Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-\u03b3. Exp. Mol. Med. 43, 169\u2013178 (2011).","journal-title":"Exp. Mol. Med."},{"key":"BFni3444_CR40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert, C. et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. J. Am. Med. Assoc. 315, 469\u2013479 (2016).","journal-title":"J. Am. Med. Assoc."},{"key":"BFni3444_CR41","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel, S. et al. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 368, 2455\u20132466 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFni3444_CR42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","volume":"371","author":"LA Beck","year":"2014","unstructured":"Beck, L.A. et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N. Engl. J. Med. 371, 130\u2013139 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFni3444_CR43","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","volume":"118","author":"P Gevaert","year":"2006","unstructured":"Gevaert, P. et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J. Allergy Clin. Immunol. 118, 1133\u20131141 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFni3444_CR44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert, P. et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J. Allergy Clin. Immunol. 128, 989\u2013995 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFni3444_CR45","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren, J. et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088\u20131098 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFni3444_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chom.2015.06.011","volume":"18","author":"MC Abt","year":"2015","unstructured":"Abt, M.C. et al. innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18, 27\u201337 (2015).","journal-title":"Cell Host Microbe"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni.3444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.3444","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.3444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:10:41Z","timestamp":1684433441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.3444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,25]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFni3444"],"URL":"https:\/\/doi.org\/10.1038\/ni.3444","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,25]]},"assertion":[{"value":"20 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}